PDIC

BioSyent Announces Launch of New FeraMAX® Pd Powder 15

Retrieved on: 
Tuesday, October 19, 2021
PD, RX, The Medical Post, PDIC, TSX, Pharmacist, Polysaccharide, Molecule, Pharmacy, OTC, Lactose, TSX Venture Exchange, GLOBE, Patient, Blockchain.com, Physician, Profession, Company, Palladium, Pharmaceutical industry

MISSISSAUGA, Ontario, Oct. 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (BioSyent, the Company, TSX Venture: RX) is pleased to announce the launch of FeraMAX Pd Powder 15 by its subsidiary, BioSyent Pharma Inc., in Canada.

Key Points: 
  • MISSISSAUGA, Ontario, Oct. 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (BioSyent, the Company, TSX Venture: RX) is pleased to announce the launch of FeraMAX Pd Powder 15 by its subsidiary, BioSyent Pharma Inc., in Canada.
  • FeraMAX Pd Powder 15 is the second product incorporating Polydextrose-Iron Complex (PDIC), a patented oral iron supplement delivery system.
  • FeraMAX Pd Powder 15 is presented in new packaging, appealing to children with its new mascot, Max the monkey.
  • FeraMAX Pd Powder 15 will replace FeraMAX Powder at Canadian pharmacies and shipments in an 83g bottle configuration have commenced.